Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2022-01-04
Original market date: See footnote 1
2020-12-23
Product name:
ODOMZO
DIN:
02500337
Product Monograph/Veterinary Labelling:
Date:
2021-12-31
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Sun House, Plot 201 B/1, Western Express Highway, Goregaon (E)
Mumbai
Maharashtra
India
400063
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01XJ02 SONIDEGIB
Active ingredient group (AIG) number:See footnote5
0162314001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| SONIDEGIB (SONIDEGIB PHOSPHATE) | 200 MG |
| Additional Risk Minimization Measures |
|---|
| Controlled Distribution Program |
| Patient Consent |
| Healthcare Professional Checklist |